I'm guessing we'll get an updated 3B tonight. If that's causing some of the pressure behind the selling then we should be clear of it.
Surprise anns notwithstanding, the next impetus for SP might come from the AGM which is end of April. That will hopefully set all our minds at rest with the other trials and maybe we'll get feedback on the interactions with the FDA for Rett.
Honestly though I'm not expecting too much from the AGM. That's not a complaint, it's just that the timing's a bit early.
Ann: Annual Report to shareholders, page-16
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.65 |
Change
-0.540(2.81%) |
Mkt cap ! $2.383B | |||
| Open | High | Low | Value | Volume |
| $18.98 | $19.15 | $18.50 | $10.51M | 560.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1500 | $18.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.65 | 1127 | 2 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |